H. Lundbeck A/S (Lundbeck) has appointed Jacob Tolstrup as new vice president with responsibility for business development. In his new position, Tolstrup will spearhead the development and strengthening of Lundbeck's current and future partnerships. He will also be responsible for exploring new growth opportunities for Lundbeck in the form of inbound licensing of new drugs and potential acquisitions.
Jacob Tolstrup comes from a position as vice president of finance and administration at Lundbeck’s American subsidiary, Lundbeck US. Prior to that position, he had overall responsibility for Lundbeck's investor relations and corporate communications as vice president for corporate reporting, based in Lundbeck's headquarters in Valby.
Jacob Tolstrup has thus held several management positions in his more than 10 years at Lundbeck, and has been directly involved in the company's business development in a number of these positions. This has also been the case in his most recent posting, where he has worked to develop Lundbeck's activities on the important U.S. market.
Takes on a key role
As vice president of business development, Jacob Tolstrup will play a key role in the realization of Lundbeck's overall strategy and vision. He will lead global efforts to execute Lundbeck's strategic goal of maximizing existing partnerships and identifying and pursuing business development opportunities that can provide the basis for long-term growth.
“Jacob has delivered strong results in a very professional manner for several years in various positions,” says Lundbeck CEO Ulf Wiinberg. “He also has significant experience in business development from the U.S. market, which is of increasing strategic importance to us. We are pleased to be able to recruit such a strong person internally to lead the important work of our on-going business development.”
About Jacob Tolstrup
Date of birth: 3 May 1972 (39 years)
Education: Graduated MSc in Business Law from Aalborg University. MBA from Germany.
Career:
2012 – Vice President, Business Development, Lundbeck
2010-2012: Vice President, Finance and Administration, Lundbeck US, Lundbeck
2010-2010: Vice President, Investor Relations and Communications (Corporate Reporting), Lundbeck
2007-2010: Divisional Director, Investor Relations and Communications, Lundbeck
2006-2007: Director of Finance for a subsidiary, and of Investor Relations, North America, Lundbeck
2001-2006: Various positions in Investor Relations, Lundbeck
1999-2001: Financial Analyst and Financial Planner, Lundbeck
1998-1999: Finance Department, Abbott Laboratories
Personal: Married to Mette, who is an upper secondary school teacher. They have three children: Claes, age eight; Maja, age eleven; and Max, age thirteen.
Jacob Tolstrup enjoys running in his leisure time. He and his family also share a passion for football, both on and off the pitch. The family tries to make time for skiing, too, and not least travelling; USA, not surprisingly, is often the preferred destination.
Additional information
Mads Kronborg, Media Relations Manager Simon Augustesen, Media Relations
Phone (direct): +45 36 43 28 51 Phone (direct): +45 36 43 49 80
About Lundbeck
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.
Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with brain disorders. In 2011, the company's revenue was DKK 16.0 billion (approximately EUR 2.2 billion or USD 3.0 billion). For more information, please visit www.lundbeck.com
